Why is GERN Up Today?
About Geron Corp
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blo...
Overall Confidence: 67%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: +0.6%
Market Comparison
🔔 Get GERN Alerts
We'll notify you when GERN's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
GERN has moved more than 3.0% up on 50 occasions in the past year.
Frequently Asked Questions
Why is GERN stock up today?
Options traders are heavily buying calls on GERN, with 87% of volume in calls. This suggests bullish institutional positioning.
Is GERN stock a buy or sell right now?
Based on current analysis, GERN shows 67% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the GERN stock price target?
GERN is currently trading at $1.01. Based on today's momentum, the expected short-term range is $0.99 - $1.04. See long-term price prediction →
Will GERN stock continue rising?
Our analysis shows a 45% probability that GERN's move continues in the next 1-3 days. Key level to watch: $1.06 (resistance).
Is GERN stock oversold or overbought?
GERN's RSI (Relative Strength Index) is currently at 44.5. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for GERN stock?
GERN's 10-day momentum indicator is at 0.05. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is GERN outperforming or underperforming the market?
GERN (+3.67%) is currently significantly outperforming the market (+2.4% vs SPY). Today, the S&P 500 (SPY) is up 1.32%, and Nasdaq (QQQ) is up 2.31%.
What does MACD indicate for GERN?
GERN's MACD (-0.07) is currently above the signal line (-0.07), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 34.1) is strong.
Is GERN in an uptrend or downtrend?
Based on moving average analysis, GERN is in a bearish trend. The price ($1.01) is trading below both the 20-day SMA ($1.06) and 50-day SMA ($1.21). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis